TheracryF PLC Market Cap History

Market Cap: £4.2 Million

GBP as of Aug 2, 2026 | US$5.6 Million

Company Profile $TCF

TheracryF PLC Market Capitalization Over Time

Evolution of TheracryF PLC market cap history

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly Market Cap Evolution

Date Market Cap YoY Change

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

Profile

TheracryF PLC is an innovative player in the pharmaceutical and biotechnology industry. This company specializes in the development and commercialization of cutting-edge therapeutic solutions. Focused on addressing unmet medical needs, TheracryF PLC invests heavily in research and development to bring new drugs and treatments to market. The company's portfolio includes a range of products targeting various critical health conditions, enhancing patient care and improving life quality. By partnering with healthcare providers, research institutions, and regulatory bodies, TheracryF PLC ensures the safe and efficient deployment of its pharmaceutical products. As a pivotal entity in the biotech sector, TheracryF PLC contributes significantly to healthcare advancements, fostering medical innovation and supporting public health initiatives worldwide. Its strategic initiatives and rigorous approach to product development underscore its relevance and impact within the global financial markets, making it a key entity to watch in the ever-evolving landscape of healthcare solutions.

Stocks & Indexes

TheracryF PLC main stocks and indexes inclusions.

$TCF
FTSE AIM All-Share

What is Market Capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.